PITUITARY MODULATION OF SULPIRIDE ACTION IN CENTRAL NERVOUS-SYSTEM OF RAT

被引:14
作者
PORTALEONE, P
DICARLO, R
CRISPINO, A
GENAZZANI, E
机构
[1] Institute of Pharmacology, University of Turin, Turin
关键词
D O I
10.1016/0304-3940(78)90244-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To verify whether the stimulation by sulpiride of hypothalamic adenylate cyclase was direct or mediated by release of pituitary hormones, the effect of sulpiride on female hypophysectomized rats was studied. In these animals sulpiride does not substantially modify hypothalamic adenylate cyclase, brain 3,4-dihydroxyphenylacetic acid (DOPAC) levels and serum prolactin concentrations. Chlorpromazine on the contrary inhibits hypothalamic adenylate cyclase activity and increases DOPAC levels both in intact and in hypophysectomized rats. As sulpiride hardly crosses the blood-brain barrier, its action on pituitary with prolactin release seems to be essential to start the neurochemical phenomena in the central nervous system. © 1978.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 16 条
[1]   CATECHOLAMINE CONTROL OF GROWTH-HORMONE REGULATION - EVIDENCE FOR DISCRETE CHANGES IN DOPAMINE AND NORADRENALINE TURNOVER FOLLOWING GROWTH-HORMONE ADMINISTRATION [J].
ANDERSSON, K ;
FUXE, K ;
ENEROTH, P ;
GUSTAFSSON, JA ;
SKETT, P .
NEUROSCIENCE LETTERS, 1977, 5 (1-2) :83-89
[2]   DIFFERENTIAL EFFECT OF NEUROLEPTIC DRUGS ON DOPAMINE TURNOVER IN EXTRAPYRAMIDAL AND LIMBIC SYSTEM [J].
BARTHOLINI, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (05) :429-433
[3]  
BENAKIS A, 1976, J PHARMACOL-PARIS, V7, P367
[4]   EVIDENCE FOR SELECTIVE AND LONG-LASTING STIMULATION OF REGULATORY DOPAMINE-RECEPTORS BY BROMOCRIPTINE (CB 154) [J].
DICHIARA, G ;
PORCEDDU, ML ;
VARGIU, L ;
STEFANINI, E ;
GESSA, GL .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 300 (03) :239-245
[5]   SUBSTITUTED BENZAMIDES AS CEREBRAL DOPAMINE ANTAGONISTS IN RODENTS [J].
ELLIOTT, PNC ;
JENNER, P ;
HUIZING, G ;
MARSDEN, CD ;
MILLER, R .
NEUROPHARMACOLOGY, 1977, 16 (05) :333-342
[6]  
FLUCKIGER E, 1972, PROLACTIN CARCINOGEN, P162
[7]   DOPAMINE IN NUCLEUS ACCUMBENS - PREFERENTIAL INCREASE OF DA TURNOVER BY RAT PROLACTIN [J].
FUXE, K ;
ENEROTH, P ;
GUSTAFSSON, JA ;
LOFSTROM, A ;
SKETT, P .
BRAIN RESEARCH, 1977, 122 (01) :177-182
[8]   DOPAMINE RECEPTOR BLOCKING ACTIVITY OF SULPIRIDE IN CENTRAL NERVOUS-SYSTEM [J].
HONDA, F ;
SATOH, Y ;
SHIMOMURA, K ;
SATOH, H ;
NOGUCHI, H ;
UCHIDA, SI ;
KATO, R .
JAPANESE JOURNAL OF PHARMACOLOGY, 1977, 27 (03) :397-411
[9]   COMPARISON OF INVITRO AND INVIVO DOPAMINE RECEPTOR ANTAGONISM PRODUCED BY SUBSTITUTED BENZAMIDE DRUGS [J].
JENNER, P ;
ELLIOTT, PNC ;
CLOW, A ;
REAVILL, C ;
MARSDEN, CD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (01) :46-48
[10]  
KRISHNA G, 1968, J PHARMACOL EXP THER, V163, P379